載入錯誤
看來載入頁面時發生了錯誤.
重新載入
我們的團隊已收到通知，但若此問題持續，請透過
電郵支援widget工具
聯絡我們。
A084110
10.9%
A271980
-2.9%
A002800
-2.0%
HK
前往
快閃促銷
登入
觀察名單
觀點
ProPicks AI
篩選器
數據瀏覽
圖表
已儲存工作
收起
Ilyang Pharm
KOSE:A007570
南韓 / 保健 / 製藥
加入觀察名單
貨幣
₩
綜觀
股息
財報
模型
財務狀況
比較
穩健度
圖表
10 年 DCF EBITDA 退出價
股價
10,270.00
KRW
公允價值
6,310.66
KRW
Metrics
Range
Conclusion
Discount Rate
10.3% - 9.3%
9.8%
Terminal EBITDA Multiple
18.7x - 20.7x
19.7x
Fair Value
₩5,344 - ₩7,349
₩6,311
Upside
-48.2% - -28.7%
-38.8%
0.0%
Revenue 10y CAGR
9.2%
10y Avg EBITDA Margin
-12.0%
Unlevered FCF 10y CAGR
10-Year DCF Model: EBITDA Exit
分享
儲存
股價
10,270.00
KRW
公允價值
6,310.66
KRW
看漲
-38.8%
Revenue and EBITDA
CapEx
Working Capital
D&A
Tax Rate
Discount Rate
Terminal Value
Select Revenue and EBITDA Forecast
(KRW in millions)
Input Projections
Fiscal Years Ending
Dec-24
Dec-25
Dec-26
Dec-27
Dec-28
Dec-29
Dec-30
Dec-31
Dec-32
Dec-33
Dec-34
Revenue
268,861
268,861
268,861
268,861
268,861
268,861
268,861
268,861
268,861
268,861
268,861
% Growth
0.8%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
EBITDA
20,824
24,615
24,615
24,615
24,615
24,615
24,615
24,615
24,615
24,615
24,615
% of Revenue
7.7%
9.2%
9.2%
9.2%
9.2%
9.2%
9.2%
9.2%
9.2%
9.2%
9.2%
支援算式
Calculation of Free Cash Flow
Discounting Periods
Discounting Factors
Calculation of Enterprise Value
Equity Waterfall
Historical Financials
Current Trading Multiples
Calculation of Free Cash Flow
Projected Unlevered Cash Flow
(KRW in millions)
Dec-25
Dec-26
Dec-27
Dec-28
Dec-29
Dec-30
Dec-31
Dec-32
Dec-33
Dec-34
EBITDA
24,615
24,615
24,615
24,615
24,615
24,615
24,615
24,615
24,615
24,615
Other Income / (Exp)
0
0
0
0
0
0
0
0
0
0
D&A
(11,121)
(11,121)
(11,121)
(11,121)
(11,121)
(11,121)
(11,121)
(11,121)
(11,121)
(11,121)
EBIT
13,494
13,494
13,494
13,494
13,494
13,494
13,494
13,494
13,494
13,494
Pro forma Taxes
(2,969)
(2,969)
(2,969)
(2,969)
(2,969)
(2,969)
(2,969)
(2,969)
(2,969)
(2,969)
NOPAT
8,580
10,525
10,525
10,525
10,525
10,525
10,525
10,525
10,525
10,525
10,525
Capital Expenditures
(38,200)
(21,653)
(21,912)
(27,255)
(27,255)
(27,255)
(27,255)
(27,255)
(27,255)
(27,255)
(27,255)
NWC Investment
(393)
0
0
0
0
0
0
0
0
0
0
(+) D&A
9,824
11,121
11,121
11,121
11,121
11,121
11,121
11,121
11,121
11,121
11,121
Free Cash Flow
(20,189)
(6)
(265)
(5,608)
(5,608)
(5,608)
(5,608)
(5,608)
(5,608)
(5,608)
(5,608)
% Growth
NM
NM
NM
NM
NM
NM
NM
NM
NM
NM
版權所有。
使用條款
繁體中文
English (UK)
English (India)
English (Canada)
English (Australia)
English (South Africa)
English (Philippines)
Deutsch
Español (España)
Español (México)
Français
Italiano
Nederlands
Português (Portugal)
Polski
Português (Brasil)
Русский
Türkçe
Ελληνικά
Svenska
Suomi
日本語
한국어
简体中文
Bahasa Indonesia
Bahasa Melayu
ไทย
Tiếng Việt
हिंदी